Financial Performance - The company's revenue for Q3 2021 was ¥279,336,611.18, representing a year-over-year increase of 17.57%[5] - The net profit attributable to shareholders decreased by 21.85% to ¥25,445,617.33 compared to the same period last year[5] - The net profit excluding non-recurring gains and losses increased by 191.79% to ¥24,724,995.47 for the current period[6] - Basic and diluted earnings per share were both ¥0.06, down 25.00% from the previous year[6] - Total operating revenue for the first three quarters of 2021 reached CNY 910,541,434.13, an increase of 11.97% compared to CNY 813,140,630.47 in the same period of 2020[18] - Net profit for the first three quarters of 2021 was CNY 76,080,576.63, slightly up from CNY 75,074,690.02 in the same period of 2020[19] - Basic and diluted earnings per share for the first three quarters of 2021 were both CNY 0.19, compared to CNY 0.20 in the same period of 2020[20] - The total comprehensive income for the first three quarters of 2021 was CNY 76,080,576.63, slightly higher than CNY 75,074,690.02 in the same period of 2020[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,478,428,894.37, a decrease of 2.81% from the end of the previous year[6] - Total current assets as of September 30, 2021, amount to ¥810,081,054.26, a decrease from ¥959,636,994.38 at the end of 2020[15] - Total liabilities decreased to ¥540,986,828.66 from ¥604,682,089.37 year-over-year[16] - Non-current assets increased to ¥668,347,840.11 from ¥561,522,896.87 year-over-year[15] - The company reported a decrease in total liabilities and equity to CNY 1,478,428,894.37 from CNY 1,521,159,891.25[19] - The total liabilities increased to ¥604,682,089.37 in Q3 2021 from ¥613,546,448.94 at the beginning of the year, reflecting a rise in financial obligations[26] Cash Flow - The company's cash flow from operating activities showed a net outflow of ¥24,700,295.50 for the year-to-date period[6] - Cash flow from operating activities showed a net outflow of CNY 24,700,295.50, an improvement from a net outflow of CNY 175,087,499.26 in the same period of 2020[22] - Cash inflow from operating activities totaled CNY 885,484,138.31, compared to CNY 673,577,454.69 in the previous year, indicating a growth of 31.39%[22] - The net cash flow from investing activities for Q3 2021 was -¥103,070,551.24, compared to -¥55,124,248.50 in Q3 2020, indicating a significant increase in cash outflow[23] - The total cash inflow from financing activities in Q3 2021 was ¥331,483,500.00, down from ¥438,717,620.92 in Q3 2020, reflecting a decrease of approximately 24.4%[23] - The net cash flow from financing activities for Q3 2021 was ¥14,803,011.93, a decrease of 94.9% compared to ¥290,281,790.38 in Q3 2020[23] - The cash and cash equivalents at the end of Q3 2021 stood at ¥227,909,609.21, a decrease from ¥340,877,444.02 at the beginning of the period[23] - The company reported a cash outflow of ¥112,967,834.81 for the net increase in cash and cash equivalents in Q3 2021, contrasting with an inflow of ¥60,070,042.62 in Q3 2020[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 33,798[12] - The largest shareholder, Hainan Huluwa Investment Development Co., Ltd., holds 167,079,000 shares, accounting for 41.7% of total shares[12] - The company reported a total equity attributable to shareholders of ¥933,822,081.04, reflecting a 1.89% increase from the previous year[6] - The company's total equity remained stable at ¥916,477,801.88, indicating no significant changes in shareholder equity during the period[27] Research and Development - Research and development expenses increased by 74.96% year-to-date, indicating a focus on drug development[10] - Research and development expenses increased significantly to CNY 55,627,356.28, compared to CNY 31,794,530.18 in the previous year, reflecting a growth of 74.93%[18] Other Information - The company has not disclosed any new product developments or market expansion strategies in the current report[14] - The company executed a new leasing standard starting January 1, 2021, which resulted in adjustments to the financial statements[27] - The company recorded an investment loss of CNY 1,820,626.10, contrasting with an investment gain of CNY 950,500.89 in the previous year[18] - The weighted average return on equity decreased by 1.41 percentage points to 2.70%[6] - Cash and cash equivalents decreased to ¥227,909,609.21 from ¥345,877,444.02 year-over-year[14] - Inventory as of September 30, 2021, is ¥191,501,962.40, up from ¥185,990,670.02 year-over-year[15] - Short-term borrowings increased to ¥256,326,100.42 from ¥210,278,118.94 year-over-year[16]
葫芦娃(605199) - 2021 Q3 - 季度财报